Results 81 to 90 of about 19,437 (169)

Chronic Chylothorax in Childhood: Clinical Complexity and Management Challenges-A Case Report and Literature Overview. [PDF]

Diagnostics (Basel)
Bizerea-Moga TO, Pantea CL, Brad GF, Mărginean O, Moga TV.   +4 more
europepmc   +1 more source

Optimising Non-operative Management of Inoperable Malignant Bowel Obstruction: A Clinical Review for Surgical Practice. [PDF]

Cureus
Alkashty M, Kahka E, Hameed W, Eshra Y.
europepmc   +1 more source

Octreotide for prevention of delayed bleeding after endoscopic mucosal resection for large superficial non-ampullary duodenal tumors. [PDF]

Endosc Int Open
Van De Leur CM, Moons LM, Vleggaar F, Didden P.   +3 more
europepmc   +1 more source

Transarterial embolization combined with octreotide long-acting release in treating rectal neuroendocrine tumor liver metastases: a single-institutional experience. [PDF]

J Gastrointest Oncol
Zhao Q, Li CX, Chen LH, Liang Y, Tang W, Xu JY, Chen J, Xu LC.   +7 more
europepmc   +1 more source

Bilateral Congenital Chylothorax With Neonatal Ventilator-Associated Pneumonia and Sepsis: Diagnostic and Therapeutic Challenges: A Case Report. [PDF]

Am J Case Rep
Hajdari LB, Çekaj M, Morina BR, Morina VR.   +3 more
europepmc   +1 more source

What is the future of acromegaly therapy?

J Clin Endocrinol Metab
Schilbach K, Strasburger CJ.
europepmc   +1 more source

Uptake of ¹⁸F-AlF-NOTA-octreotide PET/CT in gastrointestinal stromal tumors. [PDF]

EJNMMI Rep
Xu X, Wang G, Zhang X, Wang R, Ma G.
europepmc   +1 more source

Sustained remission of post-Fontan protein-losing enteropathy achieved by combination therapy with high-dose spironolactone and the somatostatin analogue octreotide: a case report. [PDF]

BMC Pediatr
Suzuki E, Jimbo K, Fukunaga H, Nagata M, Kashiwagi K, Aoki K, Arai N, Miyata E, Suzuki M, Kudo T, Shoji H.   +10 more
europepmc   +1 more source

Current treatment landscape of acromegaly.

J Clin Endocrinol Metab
Castinetti F, Ioachimescu AG.
europepmc   +1 more source

Rethinking gastroenteropancreatic neuroendocrine neoplasms: A perspective on cellular origins, molecular mechanisms, and combination therapies. [PDF]

J Transl Int Med
Shi H, Xu S, Lin R.
europepmc   +1 more source